Early stage technology investment, IP management and licensing
Plant Bioscience Limited (PBL) develops innovative technologies from public and private sources worldwide - turning ideas into patented, scientifically validated and licensable technologies. PBL invests in building intellectual property protection, and develops technologies through proof-of-concept and prototype stage and licenses onwards to a wide variety of industry sectors.Our interests cover AgBiotech, Food/Nutrition, Microbiology, Biotechnology and related Life Science industries. We market our technologies internationally and have regular contact with a very wide range of industrial customers, licensees and development partners. PBL was formed in 1994, and is now jointly and equally owned by John Innes Centre, The Sainsbury Laboratory, and the BBSRC (Biotechnology and Biological Sciences Research Council).
Technology investment services for public sector researchers
We offer various options for our services but most commonly work on a fully contingent, non-fee basis, instead taking a portion of future commercial revenues, shared with the original source of the technology. We commonly cover patent costs and can inject funds directly to carry out critical proof-of-concept or technology development work.
IP management and patent advisory service for bioscience companies and investors
PBL offers bioscience companies and investors a patent consultation and management service including:
- IP identification and assessment
- IP strategy definition
- IP portfolio management
- IP due diligence
Plant Bioscience Limited
Norwich Research Park
Telephone: +44 (0)1603 456500